Prepulse Inhibition of Startle in Cocaine Dependence - 7
NCT00015249 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.
Conditions
- Cocaine-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
Amantadine
Sponsors & Collaborators
-
New York MDRU
collaborator OTHER -
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
John Rotrosen, M.D. · New York MDRU
Study Design
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-02-28
- Primary Completion
- 1998-04-30
- Completion
- 1998-05-31
Countries
- United States
Study Locations
More Related Trials
-
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000301 ·Status: COMPLETED ·Phase: PHASE2
-
Glutamatergic Modulation of Cocaine-related Deficits
NCT01790490 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
NCT00158132 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
NCT00015054 ·Status: COMPLETED ·Phase: PHASE2
-
New Medication Treatment for Stimulant Dependence
NCT00689572 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction - 3
NCT00000198 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268 ·Status: COMPLETED ·Phase: PHASE2
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
NCT00000350 ·Status: UNKNOWN ·Phase: PHASE1
-
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 ·Status: WITHDRAWN ·Phase: PHASE1
-
Impulsivity and Stimulant Administration
NCT01978431 ·Status: COMPLETED ·Phase: PHASE1
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Stress Hormones and Human Cocaine Use - 7
NCT00000290 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
NCT00136734 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
NCT01531153 ·Status: COMPLETED ·Phase: NA
-
Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates
NCT00865332 ·Status: WITHDRAWN
-
Phendimetrazine and Cocaine
NCT02233647 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Cocaine Dependence With Lisdexamfetamine
NCT00958282 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
NCT00000324 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
NCT01535937 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Brain Mechanisms in Young Adults
NCT03606473 ·Status: COMPLETED ·Phase: EARLY_PHASE1